Modern ECMO: Why an ECMO programme in a tertiary care hospital

Mauro Cotza, Giovanni Carboni, Andrea Ballotta, Hassan Kandil, Giuseppe Isgrò, Concetta Carlucci, Alessandro Varrica, Andrea Garatti, Alessandro Giamberti, Marco Ranucci

Research output: Contribution to journalArticle

Abstract

Extracorporeal Membrane Oxygenation (ECMO) represents a useful tool to support the lungs and the heart when all conventional therapies failed and the patients are at risk of death. While the Extracorporeal Life Support Organization (ELSO) collects data from different institutions that joined the Registry and reports overall outcome, individual centres often collide with results below expectations, either in adults and in paediatric population. Some authors suggest that poor outcomes could be overcome with a programme dedicated to ECMO, with specialized professionals adequately trained on ECMO and with a consistent number of procedures. In 2012, The IRCCS PSD ECMO Programme was instituted with the specific aim of achieving better results than hitherto obtained. After only 1 year of activity, the results justified the programme, with a better survival rate for each group investigated, particularly in adults, but surprisingly in paediatrics too, where the results were better than what reported by ELSO. Although the number of patients treated with ECMO is still growing up, the effects of the ECMO programme continue to exert a positive action on outcome even now. The present article reports data on survival, blood loss, and blood consumption during ECMO in the last few years at our institution.

Original languageEnglish
Pages (from-to)E79-E85
JournalEuropean Heart Journal, Supplement
Volume18
DOIs
Publication statusPublished - Apr 28 2016

Fingerprint

Extracorporeal Membrane Oxygenation
Tertiary Healthcare
Tertiary Care Centers
Organizations
Pediatrics
Registries
Survival Rate
Lung
Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Modern ECMO : Why an ECMO programme in a tertiary care hospital. / Cotza, Mauro; Carboni, Giovanni; Ballotta, Andrea; Kandil, Hassan; Isgrò, Giuseppe; Carlucci, Concetta; Varrica, Alessandro; Garatti, Andrea; Giamberti, Alessandro; Ranucci, Marco.

In: European Heart Journal, Supplement, Vol. 18, 28.04.2016, p. E79-E85.

Research output: Contribution to journalArticle

Cotza, Mauro ; Carboni, Giovanni ; Ballotta, Andrea ; Kandil, Hassan ; Isgrò, Giuseppe ; Carlucci, Concetta ; Varrica, Alessandro ; Garatti, Andrea ; Giamberti, Alessandro ; Ranucci, Marco. / Modern ECMO : Why an ECMO programme in a tertiary care hospital. In: European Heart Journal, Supplement. 2016 ; Vol. 18. pp. E79-E85.
@article{6bc0533d83f0463f841112e6b5cda826,
title = "Modern ECMO: Why an ECMO programme in a tertiary care hospital",
abstract = "Extracorporeal Membrane Oxygenation (ECMO) represents a useful tool to support the lungs and the heart when all conventional therapies failed and the patients are at risk of death. While the Extracorporeal Life Support Organization (ELSO) collects data from different institutions that joined the Registry and reports overall outcome, individual centres often collide with results below expectations, either in adults and in paediatric population. Some authors suggest that poor outcomes could be overcome with a programme dedicated to ECMO, with specialized professionals adequately trained on ECMO and with a consistent number of procedures. In 2012, The IRCCS PSD ECMO Programme was instituted with the specific aim of achieving better results than hitherto obtained. After only 1 year of activity, the results justified the programme, with a better survival rate for each group investigated, particularly in adults, but surprisingly in paediatrics too, where the results were better than what reported by ELSO. Although the number of patients treated with ECMO is still growing up, the effects of the ECMO programme continue to exert a positive action on outcome even now. The present article reports data on survival, blood loss, and blood consumption during ECMO in the last few years at our institution.",
author = "Mauro Cotza and Giovanni Carboni and Andrea Ballotta and Hassan Kandil and Giuseppe Isgr{\`o} and Concetta Carlucci and Alessandro Varrica and Andrea Garatti and Alessandro Giamberti and Marco Ranucci",
year = "2016",
month = "4",
day = "28",
doi = "10.1093/eurheartj/suw016",
language = "English",
volume = "18",
pages = "E79--E85",
journal = "European Heart Journal, Supplement",
issn = "1520-765X",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Modern ECMO

T2 - Why an ECMO programme in a tertiary care hospital

AU - Cotza, Mauro

AU - Carboni, Giovanni

AU - Ballotta, Andrea

AU - Kandil, Hassan

AU - Isgrò, Giuseppe

AU - Carlucci, Concetta

AU - Varrica, Alessandro

AU - Garatti, Andrea

AU - Giamberti, Alessandro

AU - Ranucci, Marco

PY - 2016/4/28

Y1 - 2016/4/28

N2 - Extracorporeal Membrane Oxygenation (ECMO) represents a useful tool to support the lungs and the heart when all conventional therapies failed and the patients are at risk of death. While the Extracorporeal Life Support Organization (ELSO) collects data from different institutions that joined the Registry and reports overall outcome, individual centres often collide with results below expectations, either in adults and in paediatric population. Some authors suggest that poor outcomes could be overcome with a programme dedicated to ECMO, with specialized professionals adequately trained on ECMO and with a consistent number of procedures. In 2012, The IRCCS PSD ECMO Programme was instituted with the specific aim of achieving better results than hitherto obtained. After only 1 year of activity, the results justified the programme, with a better survival rate for each group investigated, particularly in adults, but surprisingly in paediatrics too, where the results were better than what reported by ELSO. Although the number of patients treated with ECMO is still growing up, the effects of the ECMO programme continue to exert a positive action on outcome even now. The present article reports data on survival, blood loss, and blood consumption during ECMO in the last few years at our institution.

AB - Extracorporeal Membrane Oxygenation (ECMO) represents a useful tool to support the lungs and the heart when all conventional therapies failed and the patients are at risk of death. While the Extracorporeal Life Support Organization (ELSO) collects data from different institutions that joined the Registry and reports overall outcome, individual centres often collide with results below expectations, either in adults and in paediatric population. Some authors suggest that poor outcomes could be overcome with a programme dedicated to ECMO, with specialized professionals adequately trained on ECMO and with a consistent number of procedures. In 2012, The IRCCS PSD ECMO Programme was instituted with the specific aim of achieving better results than hitherto obtained. After only 1 year of activity, the results justified the programme, with a better survival rate for each group investigated, particularly in adults, but surprisingly in paediatrics too, where the results were better than what reported by ELSO. Although the number of patients treated with ECMO is still growing up, the effects of the ECMO programme continue to exert a positive action on outcome even now. The present article reports data on survival, blood loss, and blood consumption during ECMO in the last few years at our institution.

UR - http://www.scopus.com/inward/record.url?scp=84966659343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966659343&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/suw016

DO - 10.1093/eurheartj/suw016

M3 - Article

AN - SCOPUS:84966659343

VL - 18

SP - E79-E85

JO - European Heart Journal, Supplement

JF - European Heart Journal, Supplement

SN - 1520-765X

ER -